Skip to content

Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT07647627
Enrollment
Unknown
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an expanded access program (EAP) for eligible participants designed to provide access to Dibotatug (DR-01). Physician-requested expanded access will generally only be considered for patients not otherwise eligible for an ongoing clinical study sponsored by Dren Bio and provided that other program eligibility criteria are also met.

Interventions

DRUGDibotatug

Sponsors

Dren Bio
Lead SponsorINDUSTRY

Eligibility

Contacts

CONTACTExpanded Access Central Contact
expanded.access.inquiry@drenbio.com415-737-5277

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026